Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-07

Clinical Trial Update: PRESERVE-Zenith® Iliac Branch System Clinical Extended Study

View source ↗

Summary

An update on the PRESERVE-Zenith Iliac Branch System extended clinical trial indicates the study is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRESERVE-Zenith Iliac Branch System

Snippet

Sponsor: Cook Group Incorporated | Conditions: Aorto-iliac Aneurysms, Iliac Aneurysms | Status: NO_LONGER_AVAILABLE